GS1, received on 17 December, 2013 accreditation by the U.S. Food and Drug Administration (FDA) as issuing agency for unique device identifiers (UDIs). In this interview, Ulrike Kreysa Vice President of Healthcare for GS1 global office, speaks to Andrea Charles from Pharma IQ about the importance of aligning master data, how the FDA final rule for UDIs is impacting the landscape and what's next for European regulation.
Pharma IQ: The FDA final rule for UDIs came out last year. How...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
SmartLab Exchange Europe
February 25 - 26, 2025
Novotel Amsterdam City, Netherlands
Register Now |
View Agenda |
Learn More
SmartLab Exchange USA 2025
08 - 09 April, 2025
Le Méridien, Fort Lauderdale, Florida, USA
Register Now |
View Agenda |
Learn More